Jochen Lorch
MD, MSc
Director, Thyroid Cancer Program
👥Biography 个人简介
Jochen Lorch directs the Thyroid Cancer Program at Dana-Farber Cancer Institute and is internationally recognized for his work on advanced RAI-refractory differentiated thyroid cancer. He has led studies on combining lenvatinib with pembrolizumab and other immunotherapy-TKI combinations. His research addresses tumor immunology and mechanisms of resistance to systemic therapy in thyroid cancer. He is a principal investigator on multiple NCI-funded thyroid cancer trials.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jochen Lorch 的研究动态
Follow Jochen Lorch's research updates
留下邮箱，当我们发布与 Jochen Lorch（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment